Skip to main content
OpenTrials

Clinical trial condition

Stage 0a Bladder Cancer AJCC v8

Explore clinical trials studying Stage 0a Bladder Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

12 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Stage 0a Bladder Cancer AJCC v8 trial results

Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

NCT07000084

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
View all 58 locations
View Trial Details
Active, not recruiting

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

NCT04164082

Conditions
Bladder Flat Urothelial Carcinoma In Situ, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 390 locations
View Trial Details
Active, not recruiting

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

NCT05843448

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, +12 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details

Related conditions